APO Research
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global GLP-1 Drugs Industry Growth and Trends Forecast to 2032

27 December 202593 pages

Choose your research edition.

Industry ResearchGLP-1 Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Drugs Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal GLP-1 Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global GLP-1 Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for GLP-1 Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for GLP-1 Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GLP-1 Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GLP-1 Drugs include AstraZeneca, Eli Lilly, GSK, Novo Nordisk, Sanofi, Shanghai Renhui Biopharmaceutical, Sino Biopharm and Huadong Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global GLP-1 Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The GLP-1 Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GLP-1 Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GLP-1 Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global GLP-1 Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

GLP-1 Drugs Market by Company

AstraZeneca

Eli Lilly

GSK

Novo Nordisk

Sanofi

Shanghai Renhui Biopharmaceutical

Sino Biopharm

Huadong Medicine

GLP-1 Drugs Segment by Type

Albiglutide

Exenatide

Beinaglutide

Dulaglutide

Liraglutide

Lixisenatide

Semaglutide

GLP-1 Drugs Segment by Application

Type 2 Diabetes

Obesity

GLP-1 Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GLP-1 Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of GLP-1 Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Albiglutide Table 2. Major Company of Exenatide Table 3. Major Company of Beinaglutide Table 4. Major Company of Dulaglutide Table 5. Major Company of Liraglutide Table 6. Major Company of Lixisenatide Table 7. Major Company of Semaglutide Table 8. Global GLP-1 Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global GLP-1 Drugs Sales by Type (2021-2026) & (K Units) Table 10. Global GLP-1 Drugs Sales Market Share in Volume by Type (2021-2026) Table 11. Global GLP-1 Drugs Sales by Type (2021-2026) & (US$ Million) Table 12. Global GLP-1 Drugs Sales Market Share in Value by Type (2021-2026) Table 13. Global GLP-1 Drugs Price by Type (2021-2026) & (US$/Unit) Table 14. Global GLP-1 Drugs Sales by Type (2027-2032) & (K Units) Table 15. Global GLP-1 Drugs Sales Market Share in Volume by Type (2027-2032) Table 16. Global GLP-1 Drugs Sales by Type (2027-2032) & (US$ Million) Table 17. Global GLP-1 Drugs Sales Market Share in Value by Type (2027-2032) Table 18. Global GLP-1 Drugs Price by Type (2027-2032) & (US$/Unit) Table 19. North America GLP-1 Drugs Sales by Type (2021-2026) & (K Units) Table 20. North America GLP-1 Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Europe GLP-1 Drugs Sales by Type (2021-2026) & (K Units) Table 22. Europe GLP-1 Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific GLP-1 Drugs Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific GLP-1 Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America GLP-1 Drugs Sales by Type (2021-2026) & (K Units) Table 26. Latin America GLP-1 Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa GLP-1 Drugs Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa GLP-1 Drugs Sales by Type (2021-2026) & (US$ Million) Table 29. GLP-1 Drugs Industry Trends Table 30. GLP-1 Drugs Industry Drivers Table 31. GLP-1 Drugs Industry Opportunities and Challenges Table 32. GLP-1 Drugs Industry Restraints Table 33. Global GLP-1 Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global GLP-1 Drugs Revenue Market Share by Company (2021-2026) Table 35. Global GLP-1 Drugs Sales by Company (2021-2026) & (K Units) Table 36. Global GLP-1 Drugs Sales Share by Company (2021-2026) Table 37. Global GLP-1 Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global GLP-1 Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global GLP-1 Drugs Major Company Production Sites and Headquarters Table 40. Global GLP-1 Drugs Company, Product Type & Application Table 41. Global GLP-1 Drugs Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global GLP-1 Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global GLP-1 Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global GLP-1 Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global GLP-1 Drugs Sales Market Share in Volume by Region (2021-2026) Table 47. Global GLP-1 Drugs Sales by Region (2021-2026) & (US$ Million) Table 48. Global GLP-1 Drugs Sales Market Share in Value by Region (2021-2026) Table 49. Global GLP-1 Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global GLP-1 Drugs Sales by Region (2027-2032) & (K Units) Table 51. Global GLP-1 Drugs Sales Market Share in Volume by Region (2027-2032) Table 52. Global GLP-1 Drugs Sales by Region (2027-2032) & (US$ Million) Table 53. Global GLP-1 Drugs Sales Market Share in Value by Region (2027-2032) Table 54. Global GLP-1 Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global GLP-1 Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global GLP-1 Drugs Sales by Application (2021-2026) & (K Units) Table 57. Global GLP-1 Drugs Sales Market Share in Volume by Application (2021-2026) Table 58. Global GLP-1 Drugs Sales by Application (2021-2026) & (US$ Million) Table 59. Global GLP-1 Drugs Sales Market Share in Value by Application (2021-2026) Table 60. Global GLP-1 Drugs Price by Application (2021-2026) & (US$/Unit) Table 61. Global GLP-1 Drugs Sales by Application (2027-2032) & (K Units) Table 62. Global GLP-1 Drugs Sales Market Share in Volume by Application (2027-2032) Table 63. Global GLP-1 Drugs Sales by Application (2027-2032) & (US$ Million) Table 64. Global GLP-1 Drugs Sales Market Share in Value by Application (2027-2032) Table 65. Global GLP-1 Drugs Price by Application (2027-2032) & (US$/Unit) Table 66. North America GLP-1 Drugs Sales by Application (2021-2026) & (K Units) Table 67. North America GLP-1 Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Europe GLP-1 Drugs Sales by Application (2021-2026) & (K Units) Table 69. Europe GLP-1 Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific GLP-1 Drugs Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific GLP-1 Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America GLP-1 Drugs Sales by Application (2021-2026) & (K Units) Table 73. Latin America GLP-1 Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa GLP-1 Drugs Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa GLP-1 Drugs Sales by Application (2021-2026) & (US$ Million) Table 76. AstraZeneca Company Information Table 77. AstraZeneca Business Overview Table 78. AstraZeneca GLP-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. AstraZeneca GLP-1 Drugs Product Portfolio Table 80. AstraZeneca Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly GLP-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eli Lilly GLP-1 Drugs Product Portfolio Table 85. Eli Lilly Recent Development Table 86. GSK Company Information Table 87. GSK Business Overview Table 88. GSK GLP-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. GSK GLP-1 Drugs Product Portfolio Table 90. GSK Recent Development Table 91. Novo Nordisk Company Information Table 92. Novo Nordisk Business Overview Table 93. Novo Nordisk GLP-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Novo Nordisk GLP-1 Drugs Product Portfolio Table 95. Novo Nordisk Recent Development Table 96. Sanofi Company Information Table 97. Sanofi Business Overview Table 98. Sanofi GLP-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sanofi GLP-1 Drugs Product Portfolio Table 100. Sanofi Recent Development Table 101. Shanghai Renhui Biopharmaceutical Company Information Table 102. Shanghai Renhui Biopharmaceutical Business Overview Table 103. Shanghai Renhui Biopharmaceutical GLP-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shanghai Renhui Biopharmaceutical GLP-1 Drugs Product Portfolio Table 105. Shanghai Renhui Biopharmaceutical Recent Development Table 106. Sino Biopharm Company Information Table 107. Sino Biopharm Business Overview Table 108. Sino Biopharm GLP-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sino Biopharm GLP-1 Drugs Product Portfolio Table 110. Sino Biopharm Recent Development Table 111. Huadong Medicine Company Information Table 112. Huadong Medicine Business Overview Table 113. Huadong Medicine GLP-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Huadong Medicine GLP-1 Drugs Product Portfolio Table 115. Huadong Medicine Recent Development Table 116. North America GLP-1 Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America GLP-1 Drugs Sales by Country (2021-2026) & (K Units) Table 118. North America GLP-1 Drugs Sales Market Share by Country (2021-2026) Table 119. North America GLP-1 Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America GLP-1 Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. North America GLP-1 Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America GLP-1 Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. North America GLP-1 Drugs Market Share by Country (2021-2026) Table 124. North America GLP-1 Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America GLP-1 Drugs Market Share Forecast by Country (2027-2032) Table 126. Europe GLP-1 Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe GLP-1 Drugs Sales by Country (2021-2026) & (K Units) Table 128. Europe GLP-1 Drugs Sales Market Share by Country (2021-2026) Table 129. Europe GLP-1 Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe GLP-1 Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. Europe GLP-1 Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe GLP-1 Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe GLP-1 Drugs Market Share by Country (2021-2026) Table 134. Europe GLP-1 Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe GLP-1 Drugs Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific GLP-1 Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific GLP-1 Drugs Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific GLP-1 Drugs Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific GLP-1 Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific GLP-1 Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific GLP-1 Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific GLP-1 Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific GLP-1 Drugs Market Share by Country (2021-2026) Table 144. Asia-Pacific GLP-1 Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific GLP-1 Drugs Market Share Forecast by Country (2027-2032) Table 146. Latin America GLP-1 Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America GLP-1 Drugs Sales by Country (2021-2026) & (K Units) Table 148. Latin America GLP-1 Drugs Sales Market Share by Country (2021-2026) Table 149. Latin America GLP-1 Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America GLP-1 Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America GLP-1 Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America GLP-1 Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America GLP-1 Drugs Market Share by Country (2021-2026) Table 154. Latin America GLP-1 Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America GLP-1 Drugs Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa GLP-1 Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa GLP-1 Drugs Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa GLP-1 Drugs Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa GLP-1 Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa GLP-1 Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa GLP-1 Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa GLP-1 Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa GLP-1 Drugs Market Share by Country (2021-2026) Table 164. Middle East and Africa GLP-1 Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa GLP-1 Drugs Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. GLP-1 Drugs Distributors List Table 169. GLP-1 Drugs Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. GLP-1 Drugs Image Figure 2. Global GLP-1 Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global GLP-1 Drugs Sales (2021-2032) & (K Units) Figure 5. Albiglutide Image Figure 6. Global Albiglutide Sales YoY Growth (2021-2032) & (K Units) Figure 7. Exenatide Image Figure 8. Global Exenatide Sales YoY Growth (2021-2032) & (K Units) Figure 9. Beinaglutide Image Figure 10. Global Beinaglutide Sales YoY Growth (2021-2032) & (K Units) Figure 11. Dulaglutide Image Figure 12. Global Dulaglutide Sales YoY Growth (2021-2032) & (K Units) Figure 13. Liraglutide Image Figure 14. Global Liraglutide Sales YoY Growth (2021-2032) & (K Units) Figure 15. Lixisenatide Image Figure 16. Global Lixisenatide Sales YoY Growth (2021-2032) & (K Units) Figure 17. Semaglutide Image Figure 18. Global Semaglutide Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global GLP-1 Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global GLP-1 Drugs Market Share by Type 2025 VS 2032 Figure 21. North America GLP-1 Drugs Sales Market Share in Volume by Type in 2025 Figure 22. North America GLP-1 Drugs Sales Market Share in Value by Type in 2025 Figure 23. Europe GLP-1 Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Europe GLP-1 Drugs Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific GLP-1 Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific GLP-1 Drugs Sales Market Share in Value by Type in 2025 Figure 27. Latin America GLP-1 Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Latin America GLP-1 Drugs Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa GLP-1 Drugs Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa GLP-1 Drugs Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 GLP-1 Drugs Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Type 2 Diabetes Image Figure 34. Global Type 2 Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 35. Obesity Image Figure 36. Global Obesity Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global GLP-1 Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global GLP-1 Drugs Market Share by Application 2025 VS 2032 Figure 39. North America GLP-1 Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America GLP-1 Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe GLP-1 Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe GLP-1 Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific GLP-1 Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific GLP-1 Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America GLP-1 Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America GLP-1 Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa GLP-1 Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa GLP-1 Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America GLP-1 Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America GLP-1 Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America GLP-1 Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America GLP-1 Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe GLP-1 Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe GLP-1 Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe GLP-1 Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe GLP-1 Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific GLP-1 Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific GLP-1 Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific GLP-1 Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific GLP-1 Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America GLP-1 Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America GLP-1 Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America GLP-1 Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America GLP-1 Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa GLP-1 Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa GLP-1 Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa GLP-1 Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa GLP-1 Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. GLP-1 Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. GLP-1 Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Albiglutide
  • Exenatide
  • Beinaglutide
  • Dulaglutide
  • Liraglutide
  • Lixisenatide
  • Semaglutide
Applications
  • Type 2 Diabetes
  • Obesity
Companies covered
  • AstraZeneca
  • Eli Lilly
  • GSK
  • Novo Nordisk
  • Sanofi
  • Shanghai Renhui Biopharmaceutical
  • Sino Biopharm
  • Huadong Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GLP-1 Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global GLP-1 Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 GLP-1 Drugs Market by Type
  6. 1.3.1 Albiglutide
  7. 1.3.2 Exenatide
  8. 1.3.3 Beinaglutide
  9. 1.3.4 Dulaglutide
  10. 1.3.5 Liraglutide
  11. 1.3.6 Lixisenatide
  12. 1.3.7 Semaglutide
  13. 1.4 Global GLP-1 Drugs Market Size by Type
  14. 1.4.1 Global GLP-1 Drugs Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global GLP-1 Drugs Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global GLP-1 Drugs Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America GLP-1 Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe GLP-1 Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific GLP-1 Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America GLP-1 Drugs Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa GLP-1 Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 GLP-1 Drugs Industry Trends
  2. 2.2 GLP-1 Drugs Industry Drivers
  3. 2.3 GLP-1 Drugs Industry Opportunities and Challenges
  4. 2.4 GLP-1 Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by GLP-1 Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by GLP-1 Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by GLP-1 Drugs Price (2021-2026)
  4. 3.4 Global GLP-1 Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GLP-1 Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global GLP-1 Drugs Company, Product Type & Application
  7. 3.7 Global GLP-1 Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GLP-1 Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GLP-1 Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GLP-1 Drugs Tier 1, Tier 2, and Tier 3
4 GLP-1 Drugs Regional Status and Outlook
  1. 4.1 Global GLP-1 Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global GLP-1 Drugs Historic Market Size by Region
  3. 4.2.1 Global GLP-1 Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global GLP-1 Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global GLP-1 Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global GLP-1 Drugs Forecasted Market Size by Region
  7. 4.3.1 Global GLP-1 Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global GLP-1 Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global GLP-1 Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 GLP-1 Drugs by Application
  1. 5.1 GLP-1 Drugs Market by Application
  2. 5.1.1 Type 2 Diabetes
  3. 5.1.2 Obesity
  4. 5.2 Global GLP-1 Drugs Market Size by Application
  5. 5.2.1 Global GLP-1 Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global GLP-1 Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global GLP-1 Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America GLP-1 Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe GLP-1 Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific GLP-1 Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America GLP-1 Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa GLP-1 Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca GLP-1 Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca GLP-1 Drugs Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly GLP-1 Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly GLP-1 Drugs Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK GLP-1 Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK GLP-1 Drugs Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Novo Nordisk
  20. 6.4.1 Novo Nordisk Company Information
  21. 6.4.2 Novo Nordisk Business Overview
  22. 6.4.3 Novo Nordisk GLP-1 Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novo Nordisk GLP-1 Drugs Product Portfolio
  24. 6.4.5 Novo Nordisk Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi GLP-1 Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi GLP-1 Drugs Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Shanghai Renhui Biopharmaceutical
  32. 6.6.1 Shanghai Renhui Biopharmaceutical Company Information
  33. 6.6.2 Shanghai Renhui Biopharmaceutical Business Overview
  34. 6.6.3 Shanghai Renhui Biopharmaceutical GLP-1 Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Renhui Biopharmaceutical GLP-1 Drugs Product Portfolio
  36. 6.6.5 Shanghai Renhui Biopharmaceutical Recent Developments
  37. 6.7 Sino Biopharm
  38. 6.7.1 Sino Biopharm Company Information
  39. 6.7.2 Sino Biopharm Business Overview
  40. 6.7.3 Sino Biopharm GLP-1 Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sino Biopharm GLP-1 Drugs Product Portfolio
  42. 6.7.5 Sino Biopharm Recent Developments
  43. 6.8 Huadong Medicine
  44. 6.8.1 Huadong Medicine Company Information
  45. 6.8.2 Huadong Medicine Business Overview
  46. 6.8.3 Huadong Medicine GLP-1 Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Huadong Medicine GLP-1 Drugs Product Portfolio
  48. 6.8.5 Huadong Medicine Recent Developments
7 North America by Country
  1. 7.1 North America GLP-1 Drugs Sales by Country
  2. 7.1.1 North America GLP-1 Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America GLP-1 Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America GLP-1 Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America GLP-1 Drugs Market Size by Country
  6. 7.2.1 North America GLP-1 Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America GLP-1 Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America GLP-1 Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe GLP-1 Drugs Sales by Country
  2. 8.1.1 Europe GLP-1 Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe GLP-1 Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe GLP-1 Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe GLP-1 Drugs Market Size by Country
  6. 8.2.1 Europe GLP-1 Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe GLP-1 Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe GLP-1 Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific GLP-1 Drugs Sales by Country
  2. 9.1.1 Asia-Pacific GLP-1 Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific GLP-1 Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific GLP-1 Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific GLP-1 Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific GLP-1 Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific GLP-1 Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific GLP-1 Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America GLP-1 Drugs Sales by Country
  2. 10.1.1 South America GLP-1 Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America GLP-1 Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America GLP-1 Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America GLP-1 Drugs Market Size by Country
  6. 10.2.1 South America GLP-1 Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America GLP-1 Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America GLP-1 Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa GLP-1 Drugs Sales by Country
  2. 11.1.1 Middle East and Africa GLP-1 Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa GLP-1 Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa GLP-1 Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa GLP-1 Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa GLP-1 Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa GLP-1 Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa GLP-1 Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 GLP-1 Drugs Value Chain Analysis
  2. 12.1.1 GLP-1 Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 GLP-1 Drugs Production Mode & Process
  7. 12.2 GLP-1 Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 GLP-1 Drugs Distributors
  10. 12.2.3 GLP-1 Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst